Reactive arthritis following an outbreak of Campylobacter jejuni infection

Timo Hannu1, Markku Kauppi, Marja Tuomala

  • 1Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. Timo.Hannu@ttl.fi

Abstract

Insights

The frequency of reactive arthritis (ReA) following a Campylobacter jejuni outbreak was low at 2.6%. Most ReA patients experienced mild symptoms and good outcomes, with a low association with the HLA-B27 antigen.

Area of Science:

  • Infectious Disease Epidemiology
  • Rheumatology
  • Public Health

Background:

  • Campylobacter jejuni infections can lead to reactive arthritis (ReA), a significant musculoskeletal complication.
  • Understanding the incidence and clinical presentation of ReA post-outbreak is crucial for patient management and public health surveillance.

Purpose of the Study:

  • To determine the occurrence of musculoskeletal (MSK) complications, specifically reactive arthritis (ReA), after a Campylobacter jejuni outbreak.
  • To describe the clinical characteristics and outcomes of individuals who developed MSK issues following the infection.

Main Methods:

  • A cohort of 350 individuals exposed during a 2000 C. jejuni outbreak in Finland were monitored.
  • Patients with acute MSK complaints were referred for specialist examination within 3 months of the outbreak's onset.

Main Results:

  • Nine out of 350 individuals (2.6%) were diagnosed with ReA. Other MSK diagnoses included reactive arthralgia and exacerbations of pre-existing conditions.
  • The majority of ReA patients presented with mild oligoarticular or polyarticular arthritis, primarily affecting the knees and ankles.
  • Clinical sacroiliitis was observed in one patient; 33% of ReA patients were HLA-B27 positive. Most patients showed subsiding symptoms or were symptom-free at follow-up.

Conclusions:

  • The incidence of reactive arthritis following this C. jejuni outbreak was low.
  • The clinical picture of ReA in this cohort was generally mild, with favorable outcomes and a non-elevated association with HLA-B27.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...